As AMPK is a master regulator of metabolism, its activation may improve the composition of constituents in the microenvironment between the noncancerous and tumor tissues, as well as in the extracellular fluids,59 which can generate an immune barrier. The gene discussed is PRKAA1; the disease is neoplasm.